CHARITE - UNIVERSITAETSMEDIZIN BERLIN
- Country
- Germany
- Type
- Beneficiary
- Website
- www.charite.de
- Grants received
- 410
Funding record
- 410 grants on record
- €264,940,361.24 awarded in total
- 2008–2027 years covered
This total adds up only the grants our sources publish. It is not the total funding this organisation has received.
Programmes
- Horizon Europe Framework Programme
- Seventh Framework Programme
- European Research Council
- Horizon 2020 Framework Programme
- ENIAC
145 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations funded alongside this one on two or more projects. Sharing a single project does not count. Some projects have as many as 195 participants, and appearing on the same list once is not a working relationship.
- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
- Katholieke Universiteit Leuven
- KAROLINSKA INSTITUTET
- ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
- ACADEMISCH ZIEKENHUIS LEIDEN
- ASSISTANCE PUBLIQUE HOPITAUX DE PARIS
- MEDIZINISCHE UNIVERSITAET WIEN
- CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
Calls from this organisation
No published calls from this organisation.
Grants received
- Next-generation therapeutics for vascular diseases
- Bridging Chronobiology and Physiology through Expert Training
- A doctoral training programme for next-generation LUNG-targeted non-viral GENEtic MEDicines
- Policy-Ready Operational Tools for Extreme-heat Cities and Territories
- HARPNET – Harnessing Resolution Pharmacology for Next-Generation Therapeutics
- CAPACITY BUILDING IN RESEARCH INFRASTRUCTURES TOWARDS ONE HEALTH
- Divergent evolution of drug resistance and tolerance in a fungal pathogen
- A NEW DAWN IN NEXT-GENERATION CAR-T MANUFACTURING
- Epigenetic and Genetic interplay in Liver Cancer
- EASTERN AFRICA CONSORTIUM FOR CLINICAL RESEARCH 4
- A multicenter, double-blind Phase I/II trial evaluating safety and efficacy of a fixed phage cocktail vs. placebo + DAIR in treating S. aureus prosthetic joint infections.
- INTEGRATED SERVICES FOR INFECTIOUS DISEASE OUTBREAK RESEARCH II
- CARBON-EFFICIENT BIOPRODUCTION OF CHEMICALS FROM METHANOL
- FORTIFY - FRAMEWORK FOR OPTIMIZED REGULATION, TRADE SECRETS, AND INTELLECTUAL PROPERTY IN A FEDERATED EUROPEAN HEALTH DATA SPACE
- TRANSCAN-4 : Sustained collaboration of funders to support Cancer translational research
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
We collected this from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.